August 15, 2017
Posted in Community
by Kit

  A French biotechnology company, Da Volterra, is currently conducting a survey to evaluate the consequences of Clostridium difficile infections (CDI) on the quality of life of patients during the acute infection. This study will also explore the post-CDI symptoms that patients might experience. If you face or have faced …